LncRNA LINC00511 Acts as an Oncogene in Colorectal Cancer via Sponging miR-29c-3p to Upregulate NFIA

References

• Xu W, Zhou G, Wang H, et al. Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer. Int J Cancer. 2019. doi:10.1002/ijc.32747
   Web of Science ®Google Scholar
• Rapado-Gonzalez O, Alvarez-Castro A, Lopez-Lopez R, Iglesias-Canle J, Suarez-Cunqueiro MM, Muinelo-Romay L. Circulating microRNAs as promising biomarkers in colorectal cancer. Cancers (Basel). 2019;11. doi:10.3390/cancers11070898
   PubMedGoogle Scholar
• Chen Y, Zhang B, Jin Y, Wu Q, Cao L. MiR-27b targets PI3K p110alpha to inhibit proliferation and migration in colorectal cancer stem cell. Am J Transl Res. 2019;11:5988–5997.31632566
   PubMed Web of Science ®Google Scholar
• Ulanja MB, Beutler BD, Rishi M, et al. Colorectal cancer presentation and survival in young individuals: a retrospective cohort study. Cancers (Basel). 2018;10. doi:10.3390/cancers10120472
   Web of Science ®Google Scholar
• Murphy N, Moreno V, Hughes DJ, et al. Lifestyle and dietary environmental factors in colorectal cancer susceptibility. Mol Aspects Med. 2019;69:2–9. doi:10.1016/j.mam.2019.06.00531233770
   PubMed Web of Science ®Google Scholar
• Kleffel S, Schatton T. Tumor dormancy and cancer stem cells: two sides of the same coin? Adv Exp Med Biol. 2013;734:145–179. doi:10.1007/978-1-4614-1445-2_823143979
   PubMed Web of Science ®Google Scholar
• Lin CH, Li HY, Liu YP, et al. High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma. Ther Adv Med Oncol. 2019;11:1758835919875324. doi:10.1177/175883591987532431632466
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang N, Zhang X, Liu H, Yang S. LncRNA ZEB1-AS1 down-regulation suppresses the proliferation and invasion by inhibiting ZEB1 expression in oesophageal squamous cell carcinoma. J Cell Mol Med. 2019;23(12):8206–8218. doi:10.1111/jcmm.1469231638344
   PubMed Web of Science ®Google Scholar
• Yan S, Wang P, Wang J, et al. Long non-coding RNA HIX003209 promotes inflammation by sponging miR-6089 via TLR4/NF-kappaB signaling pathway in rheumatoid arthritis. Front Immunol. 2019;10:2218. doi:10.3389/fimmu.2019.0221831620132
   PubMed Web of Science ®Google Scholar
• Zhang X, Gong J, Lu J, et al. Long noncoding RNA LINC00337 accelerates the non-small-cell lung cancer progression through inhibiting TIMP2 by recruiting DNMT1. Am J Transl Res. 2019;11:6075–6083.31632575
   PubMed Web of Science ®Google Scholar
• Shi J, Li J, Yang S, et al. LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-beta pathway and IL-6/JAK2/STAT3 pathway. J Cell Physiol. 2019. doi:10.1002/jcp.29194
   Web of Science ®Google Scholar
• Jiang L, Xie X, Ding F, Mei J, Bi R. Silencing LINC00511 inhibits cell proliferation, migration and EMT via PTEN/AKT/FOXO1 signaling pathway in lung cancer. Biochem Cell Biol. 2019;1–8. doi:10.1139/bcb-2018-0364
   PubMedGoogle Scholar
• Liu R, Wang L, Gan T, Pan T, Huang J, Bai M. Long noncoding RNA LINC00511 promotes cell growth and invasion in triple-negative breast cancer by interacting with Snail. Cancer Manag Res. 2019;11:5691–5699. doi:10.2147/cmar.S20345531417312
   PubMed Web of Science ®Google Scholar
• Chen Y, Bao C, Zhang X, Lin X, Fu Y. Knockdown of LINC00511 promotes radiosensitivity of thyroid carcinoma cells via suppressing JAK2/STAT3 signaling pathway. Cancer Biol Ther. 2019;20:1249–1257. doi:10.1080/15384047.2019.161756931135274
   PubMed Web of Science ®Google Scholar
• Lu G, Li Y, Ma Y, et al. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis. J Exp Clin Cancer Res. 2018;37:289. doi:10.1186/s13046-018-0945-630482236
   PubMed Web of Science ®Google Scholar
• Shi H, Shen H, Xu J, Zhao S, Yao S, Jiang N. MiR-143-3p suppresses the progression of ovarian cancer. Am J Transl Res. 2018;10:866–874.29636876
   PubMed Web of Science ®Google Scholar
• Zhao X, Liu Y, Li Z, et al. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma. J Cell Mol Med. 2018;22:655–667. doi:10.1111/jcmm.1335128984028
   PubMed Web of Science ®Google Scholar
• Ding J, Yang C, Yang S. LINC00511 interacts with miR-765 and modulates tongue squamous cell carcinoma progression by targeting LAMC2. J Oral Pathol Med. 2018;47:468–476. doi:10.1111/jop.1267729315846
   PubMed Web of Science ®Google Scholar
• Liao K, Lin Y, Gao W, et al. Blocking lncRNA MALAT1/miR-199a/ZHX1 axis inhibits glioblastoma proliferation and progression. Mol Ther Nucleic Acids. 2019;18:388–399. doi:10.1016/j.omtn.2019.09.00531648104
   PubMedGoogle Scholar
• Chen RY, Ju Q, Feng LM, Yuan Q, Zhang L. The carcinogenic complex lncRNA FOXP4-AS1/EZH2/LSD1 accelerates proliferation, migration and invasion of gastric cancer. Eur Rev Med Pharmacol Sci. 2019;23:8371–8376. doi:10.26355/eurrev_201910_1914831646567
   PubMed Web of Science ®Google Scholar
• Kong FR, Lv YH, Yao HM, Zhang HY, Zhou Y, Liu SE. LncRNA PCAT6 promotes occurrence and development of ovarian cancer by inhibiting PTEN. Eur Rev Med Pharmacol Sci. 2019;23:8230–8238. doi:10.26355/eurrev_201910_1913231646553
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li KF. Karyopherin beta1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression. Biomed Pharmacother. 2019;120:109127. doi:10.1016/j.biopha.2019.10912731629952
   PubMed Web of Science ®Google Scholar
• Shen X, Bai Y, Luo B, Zhou X. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer. Biol Res. 2017;50:32. doi:10.1186/s40659-017-0136-528969673
   PubMed Web of Science ®Google Scholar
• Yu C, Zhang F. LncRNA AC009022.1 enhances colorectal cancer cells proliferation, migration, and invasion by promoting ACTR3B expression via suppressing miR-497-5p. J Cell Biochem. 2019. doi:10.1002/jcb.29428
   Web of Science ®Google Scholar
• D’Angelo B, Benedetti E, Cimini A, Giordano A. MicroRNAs: a puzzling tool in cancer diagnostics and therapy. Anticancer Res. 2016;36:5571–5575. doi:10.21873/anticanres.1114227793880
   PubMed Web of Science ®Google Scholar
• Wu H, Zhang W, Wu Z, et al. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma. Cell Death Dis. 2019;10:48. doi:10.1038/s41419-018-1281-730718452
   PubMed Web of Science ®Google Scholar
• Han Y, Wu N, Jiang M, et al. Long non-coding RNA MYOSLID functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-29c-3p in gastric cancer. Cell Prolif. 2019;e12678. doi:10.1111/cpr.1267831497917
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang J, Zheng K, et al. Long noncoding RNAs sustain high expression levels of exogenous octamer-binding protein 4 by sponging regulatory microRNAs during cellular reprogramming. J Biol Chem. 2019;294(47):17863–17874. doi:10.1074/jbc.RA119.01028431624145
   PubMed Web of Science ®Google Scholar
• Chen HH, Zong J, Wang SJ. LncRNA GAPLINC promotes the growth and metastasis of glioblastoma by sponging miR-331-3p. Eur Rev Med Pharmacol Sci. 2019;23:262–270. doi:10.26355/eurrev_201901_1677230657584
   PubMed Web of Science ®Google Scholar
• Huang L, Jiang X, Kang P, et al. Long non-coding RNA NNT-AS1 functions as an oncogenic gene through modulating miR-485/BCL9 in cholangiocarcinoma. Cancer Manag Res. 2019;11:7739–7749. doi:10.2147/cmar.S20780131616187
   PubMed Web of Science ®Google Scholar
• Liu L, Zhu Y, Liu AM, Feng Y, Chen Y. Long noncoding RNA LINC00511 involves in breast cancer recurrence and radioresistance by regulating STXBP4 expression via miR-185. Eur Rev Med Pharmacol Sci. 2019;23:7457–7468. doi:10.26355/eurrev_201909_1885531539133
   PubMed Web of Science ®Google Scholar
• Dong XZ, Song Y, Lu YP, Hu Y, Liu P, Zhang L. Sanguinarine inhibits the proliferation of BGC-823 gastric cancer cells via regulating miR-96-5p/miR-29c-3p and the MAPK/JNK signaling pathway. J Nat Med. 2019;73:777–788. doi:10.1007/s11418-019-01330-731243669
   PubMed Web of Science ®Google Scholar
• Wang H, Fu L, Wei D, et al. MiR-29c-3p suppresses the migration, invasion and cell cycle in esophageal carcinoma via CCNA2/p53 axis. Front Bioeng Biotechnol. 2020;8:75. doi:10.3389/fbioe.2020.0007532154226
   PubMed Web of Science ®Google Scholar
• Xu H, Mao HL, Zhao XR, Li Y, Liu PS. MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer. J Ovarian Res. 2020;13:31. doi:10.1186/s13048-020-00631-w32192508
   PubMed Web of Science ®Google Scholar
• Yang B, Zhou ZH, Chen L, et al. Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma. Cancer Med. 2018;7:1756–1765. doi:10.1002/cam4.143429577671
   PubMed Web of Science ®Google Scholar
• Yu X, Wang M, Zuo J, et al. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor kappaB pathway. Life Sci. 2019;236:116917. doi:10.1016/j.lfs.2019.11691731614149
   PubMed Web of Science ®Google Scholar
• Wu X, Chen H, Zhang G, et al. MiR-212-3p inhibits cell proliferation and promotes apoptosis by targeting nuclear factor IA in bladder cancer. J Biosci. 2019;44. doi:10.1007/s12038-019-9903-5
   Web of Science ®Google Scholar